Rasselet Benjamin, Larbi Ahmed, Viala Pierre, Molinari Nicolas, Tetreau Raphael, Faruch-Bilfeld Marie, Taourel Patrice, Cyteval Catherine
Medical Imaging Department and Biostatistics Department, Montpellier University Hospital, 191 Avenue du Doyen Gaston Giraud, 34 295 Montpellier Cedex 5, France.
Medical Imaging Department, Nimes University Hospital, 4 rue du Professeur Robert Debré, 30029 Nîmes, France.
Eur J Radiol. 2017 Jan;86:1-5. doi: 10.1016/j.ejrad.2016.10.029. Epub 2016 Oct 29.
This was a single center, retrospective observational study.
to investigate-in a cancer population-the prevalence and hallmarks of intravertebral enhancement (IVE) detected on contrast-enhanced CT.
Intravertebral enhancements secondary to iodinated contrast stagnation have been described. Cancer patients have an increased risk of perivertebral venous thrombosis or stenosis secondary to several risk factors (cancer or drug induced hypercoagulability, deterioration of venous flow linked to catheter insertion, prolonged immobilization). In case of a high density lesion identified on CT, the diagnostic choice between metastasis and contrast media within bone marrow vessels may be an issue, especially as oncologic follow-up CT scans are usually performed with contrast medium injection.
2572 contrast-enhanced body CT scans performed in cancer patients over 3 months in the medical imaging department of a university hospital were retrospectively reviewed. IVE was sought when paravertebral venous collateral circulation was detected and bone metastasis ruled out and classified as linear or nodular. Their locations within vertebra, their relation to the injection side and the predominant collateral venous network side were evaluated.
Sixty-seven (2.8%) patients had a collateral paravertebral venous system and among them 21 had IVE (37%). There were 208 IVE locations involving 75 vertebrae. 199 IVE were linear-shaped (95.7%) and 9 nodular-shaped (4.3%). 80.8% were located between C6 and T4. 88.9% were localized in the vertebral body. 73.1% were located medially or ipsilateral to the injection side.
Intravertebral enhancement is found in 37% of the patients with paraspinal collateral venous circulation when a CT scan is performed for cancer. The ipsilateral or medial position of the IVE relative to the injection side and the side of the dominant perivertebral venous system, and the possibility of connecting the IVE to a paravertebral vein may be in favor of vascular opacification.
这是一项单中心回顾性观察研究。
在癌症患者群体中,调查对比增强CT检测到的椎体内强化(IVE)的患病率及特征。
已描述了因碘化造影剂滞留继发的椎体内强化。癌症患者因多种危险因素(癌症或药物引起的高凝状态、与导管插入相关的静脉血流恶化、长期制动),发生椎旁静脉血栓形成或狭窄的风险增加。在CT上发现高密度病变时,骨髓血管内转移瘤与造影剂之间的诊断选择可能是个问题,尤其是在肿瘤学随访CT扫描通常通过注射造影剂进行的情况下。
回顾性分析某大学医院医学影像科在3个月内为癌症患者进行的2572例对比增强体部CT扫描。当检测到椎旁静脉侧支循环且排除骨转移时,寻找IVE,并将其分类为线性或结节状。评估它们在椎体内的位置、与注射侧的关系以及主要侧支静脉网络侧。
67例(2.8%)患者有椎旁静脉侧支系统,其中21例有IVE(37%)。有208个IVE部位,累及75个椎体。199个IVE呈线性(95.7%),9个呈结节状(4.3%)。80.8%位于C6和T4之间。88.9%位于椎体。73.1%位于注射侧的内侧或同侧。
在为癌症患者进行CT扫描时,37%有椎旁侧支静脉循环的患者存在椎体内强化。IVE相对于注射侧和主要椎旁静脉系统侧的同侧或内侧位置,以及将IVE与椎旁静脉相连的可能性可能支持血管造影剂充盈。